 Bethany Veo
Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 7 | 2025 | 179 | 2.220 |
Why?
| | Medulloblastoma | 7 | 2025 | 218 | 2.180 |
Why?
| | Proto-Oncogene Proteins c-myc | 4 | 2025 | 163 | 0.790 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 661 | 0.670 |
Why?
| | Peptide Chain Initiation, Translational | 2 | 2012 | 44 | 0.660 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 840 | 0.650 |
Why?
| | tau Proteins | 2 | 2012 | 96 | 0.630 |
Why?
| | DNA Repair | 1 | 2021 | 240 | 0.590 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2025 | 1439 | 0.480 |
Why?
| | RNA, Messenger | 3 | 2012 | 2815 | 0.430 |
Why?
| | Repressor Proteins | 4 | 2019 | 426 | 0.390 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.390 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3502 | 0.320 |
Why?
| | Receptors, Dopamine D2 | 2 | 2019 | 95 | 0.280 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 68 | 0.230 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2025 | 51 | 0.230 |
Why?
| | Caenorhabditis elegans Proteins | 3 | 2013 | 205 | 0.230 |
Why?
| | Radiation Tolerance | 1 | 2025 | 104 | 0.230 |
Why?
| | Protein Biosynthesis | 2 | 2025 | 439 | 0.210 |
Why?
| | Glioblastoma | 2 | 2019 | 344 | 0.210 |
Why?
| | Mice | 9 | 2025 | 17969 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 341 | 0.190 |
Why?
| | Transcription, Genetic | 2 | 2025 | 1486 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2025 | 2502 | 0.180 |
Why?
| | Chromatin | 1 | 2025 | 536 | 0.180 |
Why?
| | Animals | 13 | 2025 | 37328 | 0.170 |
Why?
| | Caenorhabditis elegans | 3 | 2013 | 325 | 0.170 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2600 | 0.160 |
Why?
| | RNA Cap Analogs | 2 | 2010 | 6 | 0.160 |
Why?
| | Neuroblastoma | 2 | 2012 | 162 | 0.150 |
Why?
| | Brain Neoplasms | 2 | 2019 | 1282 | 0.140 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 725 | 0.140 |
Why?
| | Locomotion | 1 | 2018 | 106 | 0.130 |
Why?
| | Corpus Striatum | 1 | 2018 | 174 | 0.130 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 917 | 0.120 |
Why?
| | Pharynx | 2 | 2013 | 61 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1483 | 0.110 |
Why?
| | SOXB1 Transcription Factors | 1 | 2015 | 66 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 411 | 0.110 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1250 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 200 | 0.110 |
Why?
| | RNA, Small Interfering | 3 | 2015 | 627 | 0.110 |
Why?
| | CRISPR-Cas Systems | 2 | 2025 | 154 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2015 | 160 | 0.100 |
Why?
| | Organogenesis | 1 | 2013 | 61 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 334 | 0.100 |
Why?
| | RNA, Ribosomal | 1 | 2012 | 168 | 0.090 |
Why?
| | Humans | 11 | 2025 | 141284 | 0.090 |
Why?
| | Pluripotent Stem Cells | 1 | 2012 | 80 | 0.090 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 129 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 605 | 0.090 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 959 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2010 | 7 | 0.080 |
Why?
| | Trans-Splicing | 1 | 2010 | 12 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2010 | 33 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 858 | 0.080 |
Why?
| | Neurons | 1 | 2018 | 1611 | 0.080 |
Why?
| | Luciferases, Firefly | 1 | 2009 | 3 | 0.080 |
Why?
| | Luciferases, Renilla | 1 | 2009 | 4 | 0.070 |
Why?
| | Cycloheximide | 1 | 2009 | 48 | 0.070 |
Why?
| | MicroRNAs | 1 | 2015 | 693 | 0.070 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2009 | 46 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1753 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 664 | 0.070 |
Why?
| | Transfection | 1 | 2009 | 932 | 0.060 |
Why?
| | Alzheimer Disease | 1 | 2012 | 600 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2025 | 18 | 0.060 |
Why?
| | Mutation | 2 | 2012 | 4006 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2047 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 229 | 0.050 |
Why?
| | Survival Rate | 2 | 2019 | 1979 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 428 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 167 | 0.050 |
Why?
| | RNA Polymerase II | 1 | 2025 | 340 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.050 |
Why?
| | Apoptosis | 2 | 2022 | 2487 | 0.050 |
Why?
| | Female | 3 | 2025 | 75814 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2013 | 363 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 465 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1706 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 260 | 0.040 |
Why?
| | Piperazines | 1 | 2022 | 375 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4080 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2023 | 718 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 621 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 59 | 0.040 |
Why?
| | Base Sequence | 2 | 2013 | 2170 | 0.040 |
Why?
| | Pyrazoles | 1 | 2022 | 482 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 873 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 628 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 233 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 510 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2911 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 391 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2015 | 1983 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 444 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 135 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 135 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 700 | 0.030 |
Why?
| | Ligases | 1 | 2013 | 32 | 0.030 |
Why?
| | Cerebellum | 1 | 2015 | 217 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 757 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2165 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1220 | 0.020 |
Why?
| | Child | 2 | 2023 | 22390 | 0.020 |
Why?
| | Cell Dedifferentiation | 1 | 2012 | 31 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 502 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1050 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 174 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2012 | 49 | 0.020 |
Why?
| | Extracellular Space | 1 | 2012 | 128 | 0.020 |
Why?
| | Muscle Cells | 1 | 2012 | 42 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 465 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 331 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1761 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1724 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 282 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 815 | 0.020 |
Why?
| | Cell-Free System | 1 | 2010 | 52 | 0.020 |
Why?
| | Guanosine | 1 | 2010 | 41 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 368 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 59 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2146 | 0.020 |
Why?
| | Male | 4 | 2019 | 70140 | 0.020 |
Why?
| | RNA Stability | 1 | 2010 | 116 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4149 | 0.020 |
Why?
| | Genomics | 1 | 2012 | 811 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3172 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7948 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2863 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4414 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6951 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 4180 | 0.010 |
Why?
| | Aged | 1 | 2019 | 24836 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 16447 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 34658 | 0.010 |
Why?
|
|
Veo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|